Back

Transvenous carotid body ablation for resistant hypertension: main results of a multicentre safety and proof-of-principle cohort study.

26 August 2018 (11:18 - 11:36)
Organised by:
Congress Presentation Part of: Device-based therapy in hypertension Device Treatment and Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Markus Schlaich

Royal Perth Hospital - University of Western Australia, Perth (Australia)

4 More presentations in this session

Presentation thumbnail
Device-based therapy in hypertension - State of the Art
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
Evaluation of later morphologic alterations in renal artery wall and nerves in response to catheter-based renal denervation in sheep: comparison of the single-point and multiple-point RDN catheters
Professor M. Taborsky (Usti Nad Labem, CZ)
Abstract Slides Video
Presentation thumbnail
Refractory and resistant hypertension in diabetic patients: different metabolic profile, different response to renal denervation
Doctor A. Falkovskaya (Tomsk, RU)
Abstract Slides Video
Presentation thumbnail
Cancelled presentation - The sympathetic nervous system in hypertension: a rational treatment target?

Access the full session

Session thumbnail
Device-based therapy in hypertension

The Event

Event poster

ESC Congress 2018

26 August 2018 11:18 CET
You may be interested in
thumbnail
Congress Presentation
Opening: tackling the unmet need in hypertension care
thumbnail
Congress Presentation
State-of-the-art lecture on device-based hypertension management
thumbnail
Congress Presentation
Hot papers on device-based treatment of hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources